These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. The treatment of tardive dyskinesia and tardive dystonia. Simpson GM J Clin Psychiatry; 2000; 61 Suppl 4():39-44. PubMed ID: 10739330 [TBL] [Abstract][Full Text] [Related]
28. Review of incidence studies of tardive dyskinesia associated with typical antipsychotics. Glazer WM J Clin Psychiatry; 2000; 61 Suppl 4():15-20. PubMed ID: 10739326 [TBL] [Abstract][Full Text] [Related]
29. Tardive dyskinesia rates with atypical antipsychotics in older adults. Jeste DV J Clin Psychiatry; 2004; 65 Suppl 9():21-4. PubMed ID: 15189108 [TBL] [Abstract][Full Text] [Related]
30. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder. Swainston Harrison T; Perry CM Drugs; 2004; 64(15):1715-36. PubMed ID: 15257633 [TBL] [Abstract][Full Text] [Related]
32. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence. Kane JM J Clin Psychiatry; 2004; 65 Suppl 9():16-20. PubMed ID: 15189107 [TBL] [Abstract][Full Text] [Related]
33. Managing antipsychotic-induced tardive dyskinesia. Gardos G Drug Saf; 1999 Feb; 20(2):187-93. PubMed ID: 10082074 [TBL] [Abstract][Full Text] [Related]
34. Emerging drugs for antipsychotic-induced tardive dyskinesia: investigational drugs in Phase II and Phase III clinical trials. Lockwood JT; Remington G Expert Opin Emerg Drugs; 2015 Sep; 20(3):407-21. PubMed ID: 26166007 [TBL] [Abstract][Full Text] [Related]
35. Use of gamma-linolenic acid in the treatment of schizophrenia and tardive dyskinesia. Vaddadi KS Prostaglandins Leukot Essent Fatty Acids; 1992 May; 46(1):67-70. PubMed ID: 1321448 [TBL] [Abstract][Full Text] [Related]